| Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88145092 | FILING DATE | 10/05/2018 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | RATCLIFFE, ROBERT L |
L.O. ASSIGNED | 109 |
PUB INFORMATION |
|||
| RUN DATE | 08/14/2020 | ||
| PUB DATE | 03/05/2019 | ||
| STATUS | 748-STATEMENT OF USE - TO EXAMINER | ||
| STATUS DATE | 08/13/2020 | ||
| LITERAL MARK ELEMENT | NEXLIZET | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | NO | 44D | NO | 44D | NO |
| 44E | NO | 44E | NO | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | NEXLIZET |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 20-OWNER AT PUBLICATION |
| NAME | Esperion Therapeutics, Inc. |
| ADDRESS | Suite 150 3891 Ranchero Drive Ann Arbor, MI 48108 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | pharmaceutical preparations for the treatment of metabolic disease |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | 06/04/2020 | FIRST USE IN COMMERCE DATE | 06/04/2020 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 08/14/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 024 |
| 08/13/2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 023 |
| 07/28/2020 | IUAF | S | USE AMENDMENT FILED | 022 |
| 08/13/2020 | EX3G | S | EXTENSION 3 GRANTED | 021 |
| 07/28/2020 | EXT3 | S | EXTENSION 3 FILED | 020 |
| 08/13/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 019 |
| 07/28/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 018 |
| 07/28/2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 017 |
| 03/31/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 016 |
| 03/27/2020 | EX2G | S | EXTENSION 2 GRANTED | 015 |
| 03/27/2020 | EXT2 | S | EXTENSION 2 FILED | 014 |
| 03/27/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 013 |
| 10/15/2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 012 |
| 10/11/2019 | EX1G | S | EXTENSION 1 GRANTED | 011 |
| 10/11/2019 | EXT1 | S | EXTENSION 1 FILED | 010 |
| 10/11/2019 | EEXT | I | TEAS EXTENSION RECEIVED | 009 |
| 04/30/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 008 |
| 03/05/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 007 |
| 03/05/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 006 |
| 02/13/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 005 |
| 01/24/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 004 |
| 01/16/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
| 10/16/2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
| 10/09/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Jessica L. Rothstein |
| CORRESPONDENCE ADDRESS | Jessica L. Rothstein GOODWIN PROCTER LLP 620 EIGHTH AVENUE NEW YORK, NY 10018 |
| DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Esperion Therapeutics, Inc. |
| ADDRESS | Suite 150 3891 Ranchero Drive Ann Arbor, MI 48108 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Delaware |